Hwang et al.
121.4 (2C), 121.1, 119.6, 102.3; 19F NMR (470 MHz, CDCl3, 294
K) δ -60.0 (3F). Anal. Calcd for C50H33Cl2F3IrN7: N, 9.32; C,
57.09; H, 3.16. Found: N, 9.30; C, 57.09 H, 3.55.
Preparation of [(dfqx)2Ir(bppz)] (4). Procedures identical with
that of 1 were followed, using 300 mg of [(dfqx)2IrCl]2 (0.174
mmol), 87 mg of pyrazole (bppz)H (0.43 mmol), and 180 mg of
Na2CO3 (1.7 mmol) in 30 mL of 2-methoxyethanol. Dark red
crystals of [(dfqx)2Ir(bppz)] (4) were obtained from column
chromatography using hexane and EA ) 2:1 and crystallization
from a mixture of CHCl3 and methanol at RT (124 mg, 0.12 mmol,
35%). Solubility in CH2Cl2 at 28 °C: 18 mg/mL.
Preparation of [(dfqx)2IrCl]2. On the basis of a procedure
similar to that described for [(dpqx)2IrCl]2, the second chloride-
bridged complex [(dfqx)2IrCl]2 was synthesized in a yield of ∼85%.
Preparation of [(dfqx)2Ir(fppz)] (2). Procedures identical with
that of 1 were followed, using 200 mg of [(dfqx)2IrCl]2 (0.116
mmol), 61 mg of pyrazole (fppz)H (0.28 mmol), and 120 mg of
Na2CO3 (1.13 mmol) in 20 mL of 2-methoxyethanol. Dark red
crystals of [(dfqx)2Ir(fppz)] (2) were obtained from column chro-
matography using hexane and ethyl acetate (EA) ) 3:1 and
crystallization from a mixture of CHCl3 and hexane at RT (122
mg, 0.117 mmol, 51%). Solubility in CH2Cl2 at 28 °C: 6.5 mg/
mL.
1
Spectral data for 4: MS (FAB, 193Ir) m/z 1027 (M+); H NMR
(400 MHz, CDCl3, 294 K) δ 8.32 (d, JHH ) 5.2 Hz, 1H), 8.07 (d,
JHH ) 9.0 Hz, 1H), 7.96 (d, JHH ) 7.4 Hz, 1H), 7.88 (d, JHH ) 7.4
Hz, 1H), 7.83 (br, 2H), 7.54 (d, JHH ) 9.0 Hz, 1H), 7.53-7.44 (m,
3H), 7.33-7.19 (m, 7H), 7.15-7.05 (m, 5H), 6.47 (td, JHH ) 9.0,
2.6 Hz, 1H), 6.40 (ddd, JHH ) 9.0, 8.4, 2.6 Hz, 1H), 6.31 (dd, JHH
) 9.0, 2.6 Hz, 1H), 6.14 (s, 1H), 5.87 (dd, JHH ) 9.0, 2.6 Hz, 1H),
1.27 (s, 9H); 13C NMR (125 MHz, CDCl3, 294 K) δ 165.2, 164.5,
1
Spectral data for 2: MS (FAB, 193Ir) m/z 1039 (M+); H NMR
164.1 (d, JCF ) 243 Hz), 163.8 (d, JCF ) 243 Hz), 162.9 (d, JCF
)
(400 MHz, CDCl3, 294 K) δ 8.44 (d, JHH ) 5.2 Hz, 1H), 8.00 (d,
JHH ) 5.2 Hz, 1H), 7.95 (dd, JHH ) 6.8, 1.2 Hz, 1H), 7.91 (dd, JHH
) 6.8, 1.2 Hz, 1H), 7.83 (br, 2H), 7.63-7.60 (m, 1H), 7.52 (ddd,
243 Hz), 162.8, 162.1 (d, JCF ) 243 Hz), 156.5 (br, 2C), 152.6,
151.5, 148.7, 146.5, 142.4, 141.7, 141.6, 140.7, 140.1, 140.0, 138.0,
135.9, 135.6, 132.7 (d, JCF ) 9 Hz), 132.0 (d, JCF ) 9 Hz), 131.2,
131.1, 130.0, 129.7 (2C), 129.6, 128.9 (2C), 128.5 (2C), 127.2,
124.5, 122.2 (d, JCF ) 17 Hz), 120.7, 120.1 (d, JCF ) 17 Hz), 119.2,
116.1 (br, 4C), 109.4 (d, 2C, JCF ) 22 Hz), 108.7 (d, 2C, JCF ) 22
Hz), 32.3, 31.4 (3C); 19F NMR (470 MHz, CDCl3, 294 K) δ
-108.6, -109.7, -110.4, -110.8. Anal. Calcd for C52H36F4IrN7:
C, 60.81; H, 3.53; N, 9.55. Found: C, 60.39; H, 3.93; N, 9.47.
X-ray Structural Analysis. Single-crystal X-ray diffraction data
were measured on a Bruker Smart ApexCCD diffractometer using
λ(Mo KR) radiation (λ ) 0.710 73 Å). The data collection was
executed using the SMART program. Cell refinement and data
reduction were made with the SAINT program. The structure was
determined using the SHELXTL/PC program and refined using full-
matrix least squares. All non-hydrogen atoms were refined aniso-
tropically, whereas hydrogen atoms were placed at the calculated
positions and included in the final stage of refinements with fixed
parameters.
JHH ) 6.8, 5.2, 1.2 Hz, 1H), 7.48-7.44 (m, 1H). 7.42 (d, JHH
)
7.2 Hz, 1H), 7.34-7.23 (m, 9H), 7.18-7.15 (m, 2H), 7.07-7.04
(m, 1H), 6.53 (s, 1H), 6.50 (ddd, JHH ) 9.2, 8.8, 2.4 Hz, 1H), 6.44
(ddd, JHH ) 9.2, 8.8, 2.4 Hz, 1H), 6.37 (dd, JHH ) 9.2, 2.4 Hz,
1H), 5.92 (dd, JHH ) 8.8, 2.4 Hz, 1H); 13C NMR (125 MHz, CDCl3,
294 K) δ 164.2, 164.1 (d, JCF ) 234 Hz), 163.8 (d, JCF ) 234 Hz),
163.1, 163.0 (d, JCF ) 234 Hz), 162.7, 162.0 (d, JCF ) 234 Hz),
155.2, 155.0, 153.0, 151.7, 150.0, 146.9, 144.6 (q, JCF ) 36 Hz),
142.5, 141.4 (2C), 140.1 (2C), 139.8, 138.6, 135.8, 135.5, 132.9
(d, JCF ) 10 Hz), 132.2 (d, JCF ) 10 Hz), 131.6, 131.0 (br, 2C),
130.2, 129.8, 129.7, 129.0, 128.8, 126.6, 124.0, 122.6 (d, JCF ) 17
Hz), 122.3 (q, JCF ) 267 Hz), 122.2, 120.3 (d, J ) 17 Hz), 119.9,
116.5 (d, 2C, JCF ) 22 Hz), 116.0 (d, 2C JCF ) 22 Hz), 109.7 (d,
2C JCF ) 22 Hz), 109.4 (d, 2C JCF ) 22 Hz), 102.5; 19F NMR
(470 MHz, CDCl3, 294 K) δ -60.0 (3F), -108.0, -109.1, -110.2,
-110.8. Anal. Calcd for C49H27F7IrN7: C, 56.64; H, 2.62; N, 9.44;
Found: C, 56.82; H, 2.79. N, 8.99.
Selected crystal data for 1: C49H31F3N7Ir‚CH2Cl2, M ) 1051.93;
triclinic, space group P1h; a ) 11.1500(5), b ) 12.5173(5), c )
17.0626(7) Å; R ) 100.4154(8), â ) 92.6985(9), γ ) 114.9504(8)°;
V ) 2103.2(2) Å3, Z ) 2; Fcalcd ) 1.661 g cm-3; F(000) ) 1040;
crystal size ) 0.35 × 0.35 × 0.12 mm3; λ(Mo KR) ) 0.7107 Å;
Preparation of [(dfqx)2Ir(fptz)] (3). Procedures identical with
that of 1 were followed, using 330 mg of [(dfqx)2IrCl]2 (0.19 mmol),
102 mg of triazole (fptz)H (0.48 mmol), and 200 mg of Na2CO3
(1.9 mmol) in 30 mL of 2-methoxyethanol. Orange red crystals of
[(dfqx)2Ir(fptz)] (3) were obtained from column chromatography
using hexane and EA ) 2:1 and crystallization from a mixture of
CHCl3 and methanol at RT (191 mg, 0.183 mmol, 48%). Solubility
in CH2Cl2 at 28 °C: 22 mg/mL.
T ) 295(2) K; µ ) 3.361 mm-1; 9651 reflections collected (Rint
)
0.0365), maximum and minimum transmission ) 0.6885 and
0.3859; GOF on F2 ) 1.049; final R1[I > 2σ(I)] ) 0.0304 and
wR2[I > 2σ(I)] ) 0.0724; final R1(all data) ) 0.0352 and wR2(all
data) ) 0.0767; largest difference peak and hole ) 1.375 and
-0.955 e/Å3.
1
Spectral data for 3: MS (FAB, 193Ir) m/z 1040 (M+); H NMR
(500 MHz, CDCl3, 294 K) δ 8.54 (d, JHH ) 5.0 Hz, 1H), 8.26 (br,
2H) 7.97 (d, JHH ) 8.0 Hz, 1H), 7.92 (d, JHH ) 8.0, 1H), 7.90-
7.87 (m, 2H), 7.83 (br, 2H), 7.79-7.75 (m, 1H), 7.55 (t, JHH ) 7.8
Hz, 1H), 7.49-7.45 (m, 2H), 7.35-7.28 (m, 6H), 7.20-7.15 (m,
2H), 7.05 (t, JHH ) 7.8, Hz, 1H), 6.54 (ddd, JHH ) 9, 8.5, 2.5 Hz,
1H), 6.47 (td, JHH ) 9, 2.5 Hz, 1H), 6.38 (dd, JHH ) 9, 2.5 Hz,
1H), 5.95 (dd, JHH ) 9.0, 2.5 Hz, 1H); 13C NMR (125 MHz, CDCl3,
294 K) δ 164.1 (d, JCF ) 226 Hz), 163.9 (d, JCF ) 226 Hz), 163.8,
163.0 (d, JCF ) 226 Hz), 162.9, 162.5, 162.0 (d, JCF ) 226 Hz),
160.8, 156.6 (q, JCF ) 36 Hz), 152.9 (2C), 151.8, 151.0, 147.0,
142.3, 141.2, 140.8, 140.2, 140.1, 139.8, 139.4, 135.5, 135.4, 133.0
(d, JCF ) 9 Hz), 132.3 (d, J ) 9 Hz), 131.9, 131.0 (br, 2C), 130.4,
130.2, 130.1, 129.3, 129.2, 126.2, 124.8, 123.8, 122.7 (d, JCF ) 17
Hz), 121.9, 120.7 (d, JCF ) 17 Hz), 120.1 (q, JCF ) 268 Hz), 116.6
(d, 2C, JCF ) 21 Hz), 116.2 (d, 2C, JCF ) 21 Hz), 110.0 (m, 4C);
19F NMR (470 MHz, CDCl3, 294 K) δ -63.7 (3F), -107.3, -108.3,
-109.8, -110.4. Anal. Calcd for C48H26F7IrN8: C, 55.44; H, 2.52;
N, 10.77. Found: C, 54.83; H, 2.66; N, 10.47.
Device Fabrication. The light-emitting devices with the con-
figuration of ITO/poly(styrenesulfonate)-doped poly(3,4-ethylene-
dioxythiophene) (PEDOT:PSS) (35 nm)/doped emitting layer (50-
60 nm)/TPBI (30 nm)/Mg:Ag (100 nm)/Ag(100 nm) were fabricated.
The PEDOT:PSS was spin coated onto the ITO glass and dried at
80 °C for 12 h under vacuum to improve the smoothness. Films of
poly(vinylcarbazole) (PVK), consisting of 2-(4-biphenylyl)-5-(4-
tert-butylphenyl)-1,3,4-oxadiazole (PBD) (30 wt %) and different
amounts of complex 1 (0.18, 1.8, and 5.3 wt %, respectively) were
spin coated on top of the PEDOT:PSS layer using chlorobenzene
as the solvent, followed by drying at 60 °C for 3 h under vacuum.
Prior to film casting, the polymer solution was filtered through a
Teflon filter (0.45 µm) to remove the larger particulates. The 2,2′,2′′-
(1,3,5-benzenetriyl)tris[1-phenyl-1H-benimidazole] (TPBI) layer
was grown by thermal sublimation in a vacuum of 3 × 10-6 Torr
to use as the electron-transport layer, which would block holes and
1346 Inorganic Chemistry, Vol. 44, No. 5, 2005